Castro-GagoMEirísJFernández-BustilloJ. Severe myoclonic epilepsy associated with mitochondrial cytopathy. Child’s Nerv Syst. 1995;11:630–633.
3.
Castro-GagoMMartinón SánchezJMRodríguez-NuñezAHerranz FernándezJLEirís-PuñalJ. Severe myoclonic epilepsy and mitochondrial cytopathy. Childs Nerv Syst. 1997;13:570–571.
4.
CamposYMartínMAGarcía-SilvaT. Clinical heterogeneity associated with mitochondrial DNA depletion in muscle. Neuromuscul Disord. 1998;8:568–573.
5.
Fernández-JaénALeónMCMartínez-GraneroMAMartínez-BermejoALópez-MartínVPascual-CastroviejoI. Diagnosis in severe myoclonic epilepsy in childhood: study of 13 cases. Rev Neurol. 1998;26:759–762.
6.
BolszakMAnttonenAKKomulainenT. Digenic mutations in severe myoclonic epilepsy of infancy. Epilepsy Res. 2009;85:300–304.
7.
NishriDBlumkinLLevD. Hepatic coma culminating in severe brain damage in a child with a SCN1A mutation. Eur J Paediatr Neurol. 2010;14:456–459.
DravetCBureauMOguniHFukuyamaYCokarOSevere myoclonic epilepsy in infancy (Dravet syndrome). In: RogerJBureauMDravetCGentonPTassinariCAWolfP (Eds.), Epileptic Syndromes in Infancy, Childhood and Adolescents. 3rd ed.London: John Libbey & Co Ltd; 2002:81–103.